CG Oncology, Inc. Common stock
Status: Publicly traded
Direct answer
CG Oncology, Inc. Common stock is publicly traded on NASDAQ under the ticker CGON.
CG Oncology Inc. is a biotechnology company in the clinical development stage, committed to advancing and bringing to market an innovative, bladder-sparing core treatment for individuals diagnosed with bladder cancer. Their principal drug candidate, cretostimogene, is presently undergoing clinical evaluation. Its initial focus is on providing a therapeutic option for patients suffering from high-risk Non-Muscle...
Can you invest in CG Oncology, Inc. Common stock?
Yes. CG Oncology, Inc. Common stock trades publicly on NASDAQ as CGON.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CG Oncology, Inc. Common stock
Detailed equity research is provided by MarketSnap.